- Lékové interakce statinů: Překoná pitvastatin Achillovu slabinu?2011 | 1. lékařská fakulta
- Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug-Drug Interactions2016 | Farmaceutická fakulta v Hradci Králové
- MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption2017 | Farmaceutická fakulta v Hradci Králové
- Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study2023 | Farmaceutická fakulta v Hradci Králové
- Brivanib Exhibits Potential for Pharmacokinetic Drug-Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter and CYP450 Biotransformation Enzymes2019 | Farmaceutická fakulta v Hradci Králové
- Impact of drug-drug interactions on phenobarbital pharmacokinetics in pediatric patients2019 | 1. lékařská fakulta
- Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter2022 | Farmaceutická fakulta v Hradci Králové
- Paliperidon, antipsychotikum 2. generace: Účinnost, snášenlivost a lékové interakce2007 | 3. lékařská fakulta
- Evaluation of drug-drug interactions at the level of hepatic excretionPublikace bez příslušnosti k fakultě
- The pregnane X receptor gene-humanized mouse: A model for investigating drug-drug interactions mediated by cytochromes P450 3A2007 | 1. lékařská fakulta
- The pregnane X receptor gene-humanized mouse: A model for investigating drug-drug interactions mediated by cytochromes P450 3A2007 | Fakulta tělesné výchovy a sportu
- Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19)2022 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Lékové interakce statinů, jejich klinická závažnost a management2011 | Farmaceutická fakulta v Hradci Králové
- Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals2014 | Farmaceutická fakulta v Hradci Králové
- Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro2018 | Farmaceutická fakulta v Hradci Králové
- Antiepileptic drug interactions: A clinical case demonstration2011 | 2. lékařská fakulta
- Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity2017 | Farmaceutická fakulta v Hradci Králové
- Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics2013 | Farmaceutická fakulta v Hradci Králové
- Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo2021 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Monepantel induces hepatic cytochromes p450 in sheep in vitro and in vivo2015 | Farmaceutická fakulta v Hradci Králové
- Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)2013 | Farmaceutická fakulta v Hradci Králové
- Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters2017 | Farmaceutická fakulta v Hradci Králové
- Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme2020 | Farmaceutická fakulta v Hradci Králové
- The metabolism of flubendazole in human liver and cancer cell lines2018 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta2020 | Farmaceutická fakulta v Hradci Králové
- Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices2022 | Farmaceutická fakulta v Hradci Králové
- Universal efavirenz determination in transport study, rat placenta perfusion and placenta lysate by HPLC-UV2017 | Farmaceutická fakulta v Hradci Králové
- Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy2022 | Farmaceutická fakulta v Hradci Králové
- Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo2023 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study2022 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové